HYPR
NASDAQ
US
Hyperfine, Inc. - Class A Common Stock
$1,13
▲ +$0,04
(+3,67%)
Vol 221K
4
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$95.2M
ROE
-103,9%
Margin
-378,2%
D/E
0,00
Beta
1,10
52W
$1–$2
Konsensus Wall Street
8 analis · Apr 20262
Beli Kuat
5
Beli
1
Tahan
0
Jual
0
Jual Kuat
87,5%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 40,0%
Laporan Berikutnya
Mei 11, 2026
Estimasi EPS: $-0,09
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $-0,09 | — | — |
| Des 2025 | $-0,08 | $-0,05 | +$0,03 |
| Sep 2025 | $-0,11 | $-0,11 | $0,00 |
| Jun 2025 | $-0,12 | $-0,12 | +$0,00 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Pendapatan | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M |
| Laba Bersih | -$10.3M | -$10.4M | -$9.4M | -$9.2M | -$11.0M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -84.8% | -74.2% | -84.8% | -84.8% | -84.8% | -103.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -342.2% | -343.4% | -364.5% | -364.5% | -364.5% | -378.2% |
| Gross Margin | 49.3% | 46.2% | 45.8% | 45.8% | 45.8% | 46.1% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.02 | 6.07 | 5.02 | 5.02 | 5.02 | 3.63 |
Rasio Utama
ROA (TTM)
-80,5%
P/S (TTM)
8,98
P/B
1,3
EPS (TTM)
$-0,52
Pertumbuhan Pendapatan 3T
+105,0%
52W High
$2,22
52W Low
$0,53
$0,53
Rentang 52 Minggu
$2,22
Kesehatan Keuangan
Arus Kas Bebas
-$5.7M
Utang Bersih
-$21.4M
Kas
$21.6M
Total Utang
$182K
Per tanggal Sep 30, 2025
Як HYPR виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка HYPR vs аналоги Health Care
P/E
—
▼
0%
di bawah
rekan
(30,7)
vs Rekan
vs Industri
Undervalued
P/S
9,0
▲
248%
di atas
rekan
(2,6)
vs Rekan
vs Industri
Overvalued
P/B
1,3
▼
53%
di bawah
rekan
(2,8)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,7%)
vs Rekan
vs Industri
Yield rendah
Прибутковість HYPR vs аналоги Health Care
ROE
-103,9%
▼
170%
di bawah
rekan
(-38,5%)
vs Rekan
vs Industri
Lemah
Net margin
-378,2%
▼
1432%
di bawah
rekan
(-24,7%)
vs Rekan
vs Industri
Lemah
Валова маржа
46,1%
▼
13%
di bawah
rekan
(52,9%)
vs Rekan
vs Industri
Lemah
ROA
-80,5%
▼
279%
di bawah
rekan
(-21,2%)
vs Rekan
vs Industri
Lemah
Фінансове здоровʼя HYPR vs аналоги Health Care
D/E ratio
0,0
▼
100%
di bawah
rekan
(19,3)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
3,6
▲
68%
di atas
rekan
(2,2)
vs Rekan
vs Industri
Di bawah rata-rata
Beta
1,1
▲
5%
di atas
rekan
(1,1)
vs Rekan
vs Industri
Kurang volatil
Радар фундаменталів HYPR
HYPR
Median rekan
Industri
HYPR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
HYPR vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
HALE BRETT
Chief Financial Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Mar 23
24188 shs
TEISSEYRE THOMAS
Chief Operating Officer · Feb 13
821 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 12,16%Vanguard Group Inc
4,35%
$4.0M
Sio Capital Management, LLC
2,44%
$2.2M
Fosun International Ltd
2,12%
$1.9M
Northern Trust Corporation
1,64%
$1.5M
Catalio Capital Management,…
1,61%
$1.5M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait